The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors-Reference-Cited by-同舟云学术

The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors

Published:2014-05 Issue:1-2 Volume:152 Page:48-57
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Nellore Anoma,Liu Bianling,Patsoukis Nikolaos,Boussiotis Vassiliki A.,Li Lequn^ORCID

Funder

NIH

Leukemia and Lymphoma Society

HHV6 Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Pathophysiology of graft-versus-host disease;Ferrara;Semin. Hematol.,2006

2. Haematopoietic cell transplantation as immunotherapy;Appelbaum;Nature,2001

3. Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy;Champlin;Hematol. Oncol. Clin. North Am.,1999

4. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells;Reisner;Lancet,1981

5. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia;Prentice;Lancet,1982

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies;Drug Discovery Today;2023-05

2. Immunomodulatory Roles of Cell Cycle Regulators;Frontiers in Cell and Developmental Biology;2019-02-26

3. Micro-RNA and Kinase Regulatory Mechanisms and Pathways in GVHD;Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation;2019

4. Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression;Journal of Clinical Investigation;2018-01-16

5. Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy;Cancer Research;2018-01-08